Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy

por Dhirani NA, Yang Y, Somani S
Publicado 2017

Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells

por Pellosi DS, Moret F, Fraix A, Marino N, Maiolino S, Gaio E, Hioka N, Reddi E, Sortino S, Quaglia F
Publicado 2016

Inhibiting YAP in Endothelial Cells From Entering the Nucleus Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury

por Shuaishuai Gong, Huifen Ma, Fan Zheng, Juan Huang, Yuanyuan Zhang, Boyang Yu, Fang Li, Junping Kou
Publicado 2021

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month...

por Takahashi K, Ohji M, Terasaki H, Honda S, Margaron P, Guerin T, Yuzawa M
Publicado 2018

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation

por Arias L, Gómez-Ulla F, Ruiz-Moreno JM
Publicado 2016

Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics

por Shamul JG, Shah SR, Kim J, Schiapparelli P, Vazquez-Ramos CA, Lee BJ, Patel KK, Shin A, Quinones-Hinojosa A, Green JJ
Publicado 2019

Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy

por Guimei M, Alrouh S, Saber-Ayad M, Hafezi SA, Vinod A, Rawat S, Wardeh Y, Bakkour TM, El-Serafi AT
Publicado 2020

X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs

por Clement S, Chen W, Deng W, Goldys EM
Publicado 2018

Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand

por Sangroongruangsri S, Chaikledkaew U, Hanusaha P, Ratanapakorn T, Ruamviboonsuk P
Publicado 2021